Bleb Vascularity Change After Subconjunctival Injection Bevacizumab
Status:
Unknown status
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The occurrence of conjunctival scarring finally leads to the obstruction of the fistula tract
created by the filtering surgery. Vascular endothelial growth factor is thought to be a key
role in the formation of conjunctival scar, which play a pivotal role in the wound-healing
process. So it seems that the recombinant human anti-VEGF antibody could inhibit
angiogenesis, and reduce the conjunctival vascular formation in the wound-healing process
after glaucoma filtering surgery.